Skip to main content

Table 1 Association of global survival in patients with FLC to clinical and pathological characteristics.

From: Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinoma

Variable Survival (months) P (log rank)
Age   
≤ 23 years 8 ± 2 0.013
> 23 years 65 ± 19  
Gender   
male 26 ± 6 0.646
female 42 ± 27  
Surgical   
resection 60 ± 10 0.011
No resection 5 ± 2  
Surgical border   
Positive 20 ± 5 0.06
Negative 65 ± 4  
Fever   
Present 67 ± 14 0.188
Absent 26 ± 7  
Jaundice   
Present 65 ± 19 0.345
Absent 26 ± 13  
Palpable Mass   
Present 42 ± 33  
Absent 26 ± 14 0.84
Weight loss   
Present 26 ± 6 0.646
Absent 42 ± 27  
Ascites   
Present 4 ± 32 0.578
Absent 42 ± 2  
Hepatomegaly   
Present 42 ± 20 0.681
Absent 20 ± 14  
Vascular Invasion   
Present 5 ± 2 .0061
Absent 60 ± 10  
Atypia   
low 26 ± 13 0.319
Moderate 65 ± 9  
Hemoglobin   
≤ 12 26 ± 19 0.527
>12 42 ± 28  
Liver enzymes   
abnormal 26 ± 11 0.04
normal 65 ± 21  
Alkaline phosphatase   
abnormal 65 ± 44 0.682
normal 42 ± 17  
Albumin   
abnormal 5 ± 30 0.9
normal 42 ± 19  
Alfa fetoprotein   
abnormal 20 ± 21 0.672
normal 42 ± 21  
TNM   
Stage I and II 65 ± 14 0.693
III 60 ± 12  
IV 8 ± 8